Abstract
Research on dopamine (DA) and its receptors, and in particular the D2 receptor subclass, has been an intriguing and fast developing scientific field in the past 35 years. Methods of medicinal chemistry, molecular and structural biology as well as computational chemistry were used in the studies of DA receptors (DRs). Early attempts to describe DRs were based on a small amount of experimental data available and produced crude models at best. Once crystal structures of bacteriorhodopsin, rhodopsine, various G-protein coupled receptors, and finally D3 DR receptor became available, better and more detailed D2 DR receptor models emerged. These models gave us an insight into the mechanism of ligand-receptor interactions, and paved the way for the synthesis of new dopaminergic compounds, both agonists and antagonists and possible drugs for the treatment of different imbalances of the dopaminergic system. This review covers the key discoveries on the path to the creation of the D2 DR receptor model.
Keywords: 3D structure, computational chemistry, dopamine, GPCR, homology modeling, receptor.
Current Medicinal Chemistry
Title:Modeling of Dopamine D2 Receptor - Overview of 35-Year Evolution
Volume: 22 Issue: 25
Author(s): Vladimir Sukalovic, Vukic Soskic and Sladjana Kostic-Rajacic
Affiliation:
Keywords: 3D structure, computational chemistry, dopamine, GPCR, homology modeling, receptor.
Abstract: Research on dopamine (DA) and its receptors, and in particular the D2 receptor subclass, has been an intriguing and fast developing scientific field in the past 35 years. Methods of medicinal chemistry, molecular and structural biology as well as computational chemistry were used in the studies of DA receptors (DRs). Early attempts to describe DRs were based on a small amount of experimental data available and produced crude models at best. Once crystal structures of bacteriorhodopsin, rhodopsine, various G-protein coupled receptors, and finally D3 DR receptor became available, better and more detailed D2 DR receptor models emerged. These models gave us an insight into the mechanism of ligand-receptor interactions, and paved the way for the synthesis of new dopaminergic compounds, both agonists and antagonists and possible drugs for the treatment of different imbalances of the dopaminergic system. This review covers the key discoveries on the path to the creation of the D2 DR receptor model.
Export Options
About this article
Cite this article as:
Sukalovic Vladimir, Soskic Vukic and Kostic-Rajacic Sladjana, Modeling of Dopamine D2 Receptor - Overview of 35-Year Evolution, Current Medicinal Chemistry 2015; 22 (25) . https://dx.doi.org/10.2174/0929867322666150716114316
DOI https://dx.doi.org/10.2174/0929867322666150716114316 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Medical Treatment of Aortic Aneurysms in Marfan Syndrome and other Heritable Conditions
Current Cardiology Reviews Is the Clinical Use of Cannabis by Oncology Patients Advisable?
Current Medicinal Chemistry Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy
Current Neuropharmacology Visceral Adipose Tissue and Atherosclerosis
Current Vascular Pharmacology Meet Our Executive Editor
Current Traditional Medicine Editorial (Thematic Issue: Role of Antioxidants Treatments on Oxidative Stress and Calcium Entry in Neurological Disease: Focus on TRP Channels)
Current Neuropharmacology Neurogenesis and Alzheimers Disease: Biology and Pathophysiology in Mice and Men
Current Alzheimer Research Tachykinins: Role in Human Gastrointestinal Tract Physiology and Pathology
Current Drug Targets Microwave Assisted Medicinal Chemistry
Mini-Reviews in Medicinal Chemistry Codon Usage Biases in Alzheimers Disease and Other Neurodegenerative Diseases
Protein & Peptide Letters Pharmacological Modulation of Reactive Oxygen Species in Cancer Treatment
Current Drug Targets Selection of Healthy Volunteers According to their Multidrug Resistance Protein 1 Activity Does Not Affect Bioavailability of Quetiapine
Current Psychopharmacology Nicotine and Tobacco Particulate Self-Administration: Effects of Mecamylamine, SCH23390 and Ketanserin Pretreatment
Current Psychopharmacology Protective and Therapeutic Effects of Ghrelin in the Gut
Current Medicinal Chemistry Exploring Nitrostyrene as a Scaffold for a New Class a of Monoamine Oxidase Inhibitors
Letters in Drug Design & Discovery Software Implementation of BeiDou B1I Code Generator Using Matlab/Simulink
Recent Patents on Computer Science Effects of Tobacco Nicotine-Derived Nitrosamine Ketone (NNK) Exposures on Brain Alcohol Metabolizing Enzyme Activities
Drug Metabolism Letters Bibliometrics and Visualization of the Mechanisms of Parkinson's Diseases Based on Animal Models
Endocrine, Metabolic & Immune Disorders - Drug Targets Determining the Orientation and Localization of Membrane-Bound Peptides
Current Protein & Peptide Science Lobar Atrophy in Frontotemporal Dementia: Diagnostic and Prognostic Implications
Current Alzheimer Research